期刊文献+

重组铜绿假单胞菌外毒素结构域Ia片段的佐剂功效研究 被引量:1

Study on recombinant domain Ia of Pseudomonas aeruginosa exotoxin A (rEPA) as an adjuvant
下载PDF
导出
摘要 采用分子克隆技术,将铜绿假单胞菌PA103株编码的外毒素结构域Ia(DomainIa)的基因重组于原核表达载体pET42b(+)上,构建了pETEPA103蛋白表达载体。转化感受态大肠杆菌DE3。经IPTG诱导表达,初步纯化表达蛋白,用以免疫BALB/c纯系小鼠。制备小鼠脾淋巴细胞悬液,经刀豆素A(ConA)刺激后,用MTT比色法检测特异性淋巴细胞增殖反应。通过rEPA皮下注射BALB/c小鼠耳廓,诱导小鼠迟发型过敏反应(DTH)。采用特异性淋巴细胞增殖反应和DTH试验来检测pETEPA103表达蛋白所引起的小鼠细胞免疫应答水平,淋巴细胞增殖情况与DTH均可间接反映细胞免疫应答水平,进而评价重组铜绿假单胞菌外毒素(rEPA)DomainIa蛋白片段的佐剂功效。 By using molecular cloning technique, the Pseudomonas aeruginosa exotoxin A (EPA)domain Ia gene was cloned into the prokaryotic expression vector pET 42b(+), then pET EPA103 was constructed. The pET EPA103 was transformed into E.coli DE 3 and expressed by IDTG induction. The expressed protein was crudely purified. BALB/c mice were immunized with this protein at intervals of 0, 2 and 4 weeks respectively. After immunization, the suspension of mice spleen lymphocytes were prepared and stimulated by ConA . Specific lymphoproliferation was detected by MTT colorimetric assay, and DTH was induced by subcutaneous injecting rEPA into BALB/c mice. Detection of specific lymphoproliferation and DTH can reflect the response level cell mediated immunity. The study results showed that the expression protein of rEPA domain Ia could have the function of adjuvant.
出处 《微生物学免疫学进展》 2004年第4期18-21,共4页 Progress In Microbiology and Immunology
关键词 铜绿假单胞菌 外毒素 淋巴细胞增殖 迟发型过敏反应 Pseudomonas aeruginosa Exotoxin Lymphoproliferation Delay type hypersencitivity (DTH)
  • 相关文献

参考文献6

  • 1Randal L, Mrsny J,Ann L ,et al. Mucosal administration of a chimera composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibody responses[J].Vaccine1999,(17):1425-1433.
  • 2Herzenberg LA, Tokuhisa T. Epitope-specific regulation I Carrer-specific suppression[J]. Nature 1980,285:664-667.
  • 3Liu PV.The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. III.Identity of the lethal toxin produced in vitro and in vivo[J]. J Infection Disease 1966(116):481-489.
  • 4Guidi RC,Collier RJ. Exotoxin A of Pseudomonas aeruginosa evidence that domain I functions in receptor binding[J].Mol Microbiol 1987,(1):57-72.
  • 5Schutze MP, Leecrec C, Jolivet M, et al.Career-induced epitopic suppression.A major issue for future sythetic vaccine[J]. J Immunology 1985,135:2319-1322.
  • 6David J, FitxGerald,Charlotte M,et al. Characterixation of V3 loop-Pseud omonas exotoxin chimeras[J]. Biol Chem 1998,273(16):9951-9958.

同被引文献14

  • 1Liu P V. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis Ⅲ identity of the lethal toxin produced in vitro and in vivo[J].Infection Disease, 1966, 116: 481-489.
  • 2Allured V S, Collier R J, Carroll S F, et al. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Angstrom[J]. Proc Natl Acad Sci USA, 1986,83: 1320-1324.
  • 3Hwang J, Fitzgerald D J, Adhya S, et al. Functional domains of Pseudomonas exotoxin identified by deletionanalysis of gene expressed in E. coli[J].Cell, 1987, 48: 129-136.
  • 4Manhart M D, Morris R E, Bonventre P F, et al.Evidence for Pseudomonas aeruginosa troxin A.receptor on plasma membrane of toxin sensitive LM fibroblast[J]. Infection and Immunity, 1984,45: 596-603.
  • 5Kounnas M Z, Morris R E, Thompson M R, et al.The alpha 2-macroglobulin, reception/low densit liproprotein, recepto-related protein binds and interlizes Pseudomonas aeruginosa toxin A[J]. J Biol Chem, 1992, 267: 12420-12423.
  • 6Fitzgerald D J, Frying A C, Zdanovsky C B, et al.Pseudomonas aeruginosa exotoxin A related selection yields cells with altered expression of low density liproprotein receptor-related protein[J]. J Cell Biol, 1984, 129: 1533-1541.
  • 7Fitzgerald D, Morris R E, Saelinger C B. Receptormediated interlization of Pseudomonas aeruginosa exotoxin by mouse fibroblast[J]. Cell, 1980, 21: 867-873.
  • 8Wileman T, Harding C, Stani P. Receptor-mediated endocytosis[J]. J Bioche-mecal, 1985, 232: 1-14.
  • 9David N , Taylor A, Jerald Sadoff, et al. Synthesis characterization and clinical enevaluation of conjugate vaccine composed of the O-specific polysaccharides of Shigella dysenteriae tobacterial toxoid[J].Infection and Immunity, 1993, 61: 3678-3687.
  • 10Dani Cohen, Shai Ashkenazi, Manfred Green, et al.Safty and immuneogenicity of investingational.Shigella conjugate vaccine in Irsaely volunteers[J].Infection Immun, 1996, 64: 4074-4077.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部